AIM: To determine utility of transplant liver biopsy in evaluating efficacy of percutaneous transluminal angioplasty (PTA) for hepatic venous obstruction (HVOO). METHODS: Adult liver transplant patients treated with PTA for HVOO (2003-2013) at a single institution were reviewed for pre/post-PTA imaging findings, manometry (gradient with right atrium), presence of HVOO on pre-PTA and post-PTA early and late biopsy (EB and LB, < or > 60 d after PTA), and clinical outcome, defined as good (no clinical issues, non-HVOO-related death) or poor (surgical correction, recurrent HVOO, or HVOO-related death). RESULTS: Fifteen patients meeting inclusion criteria underwent 21 PTA, 658 ± 1293 d after transplant. In procedures with pre-PTA biopsy (n = 19), no difference was seen between pre-PTA gradient in 13/19 procedures with HVOO on biopsy and 6/19 procedures without HVOO (8 ± 2.4 mmHg vs 6.8 ± 4.3 mmHg; P = 0.35). Post-PTA, 10/21 livers had EB (29 ± 21 d) and 9/21 livers had LB (153 ± 81 d). On clinical follow-up (392 ± 773 d), HVOO on LB resulted in poor outcomes and absence of HVOO on LB resulted good outcomes. Patients with HVOO on EB (3/7 good, 4/7 poor) and no HVOO on EB (2/3 good, 1/3 poor) had mixed outcomes. CONCLUSION: Negative liver biopsy greater than 60 d after PTA accurately identifies patients with good clinical outcomes.
AIM: To determine utility of transplant liver biopsy in evaluating efficacy of percutaneous transluminal angioplasty (PTA) for hepatic venous obstruction (HVOO). METHODS: Adult liver transplant patients treated with PTA for HVOO (2003-2013) at a single institution were reviewed for pre/post-PTA imaging findings, manometry (gradient with right atrium), presence of HVOO on pre-PTA and post-PTA early and late biopsy (EB and LB, < or > 60 d after PTA), and clinical outcome, defined as good (no clinical issues, non-HVOO-related death) or poor (surgical correction, recurrent HVOO, or HVOO-related death). RESULTS: Fifteen patients meeting inclusion criteria underwent 21 PTA, 658 ± 1293 d after transplant. In procedures with pre-PTA biopsy (n = 19), no difference was seen between pre-PTA gradient in 13/19 procedures with HVOO on biopsy and 6/19 procedures without HVOO (8 ± 2.4 mmHg vs 6.8 ± 4.3 mmHg; P = 0.35). Post-PTA, 10/21 livers had EB (29 ± 21 d) and 9/21 livers had LB (153 ± 81 d). On clinical follow-up (392 ± 773 d), HVOO on LB resulted in poor outcomes and absence of HVOO on LB resulted good outcomes. Patients with HVOO on EB (3/7 good, 4/7 poor) and no HVOO on EB (2/3 good, 1/3 poor) had mixed outcomes. CONCLUSION: Negative liver biopsy greater than 60 d after PTA accurately identifies patients with good clinical outcomes.
Authors: J J Borsa; C P Daly; A B Fontaine; N H Patel; S J Althaus; E K Hoffer; T C Winter; H V Nghiem; J P McVicar Journal: J Vasc Interv Radiol Date: 1999-01 Impact factor: 3.464
Authors: Jonathan M Lorenz; Thuong Van Ha; Brian Funaki; Michael Millis; Jeffrey A Leef; Andrew Bennett; Jordan Rosenblum Journal: J Vasc Interv Radiol Date: 2006-11 Impact factor: 3.464
Authors: Stephen L Wang; Daniel Y Sze; Stephan Busque; Mahmood K Razavi; Stephen T Kee; Joan K Frisoli; Michael D Dake Journal: Radiology Date: 2005-06-13 Impact factor: 11.105
Authors: Francisco C Carnevale; Alexandre T Machado; Airton M Moreira; Miguel A De Gregorio; Lisa Suzuki; Uenis Tannuri; Nelson Gibelli; Joao G Maksoud; Giovanni G Cerri Journal: J Vasc Interv Radiol Date: 2008-08-29 Impact factor: 3.464
Authors: G Simó; A Echenagusia; F Camúñez; P Quevedo; I J Calleja; J P Ferreiroa; R Bañares Journal: Cardiovasc Intervent Radiol Date: 1995 Jul-Aug Impact factor: 2.740